ZINZINO AB (PUBL): PRELIMINARY SALES REPORT AUGUST 2022

Zinzino group revenue increased with a total of 16%, compared with the previous year.

The revenue in August for Zinzino's sales markets increased by 14% and amounted to SEK 103.5 (90.9) million. Faun Pharma's external sales increased by 52% and amounted to SEK 7.3 (4.8) million. Overall, the Group increased revenues by 16% to SEK 110.8 (95.7) million compared with the previous year.

Accumulated revenue for January – August 2022 increased by 4% to SEK 884.2 (850.9) million.

Revenues were distributed as follows:

Regions, mSEK	22-Aug	21-Aug	Change	YTD 2022	YTD 2021	Change
The Nordics	24.2	27.3	-11%	206.7	242.5	-15%
Central Europe	23.0	17.1	35%	168.8	142.8	18%
East Europe	25.0	24.4	2%	209.3	209.8	0%
South & West Europe	11.9	9.9	20%	98.8	91.2	8%
The Baltics	5.3	5.1	4%	45.8	46.2	-1%
North America	6.4	3.0	113%	45.5	32.1	42%
Asia-Pacific	6.9	4.1	68%	49.5	45.3	9%
Africa	0.8	0.0		4.9	0.0
Zinzino	103.5	90.9	14%	829.3	809.9	2%
Faun Pharma	7.3	4.8	52%	54.9	41.0	34%
Zinzino Group	110.8	95.7	16%	884.2	850.9	4%

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden -Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom, Belgium, Ireland

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA

-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
marketing@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 14:00 the 5th of September 2022.